Corporació Sanitaria Parc Taulí

Sabadell, Barcelona 8208

0 studies enrolling now · 2 studies all time

What they study most

Chronic Spontaneous Urticaria, Non-small Cell Lung Cancer

Studies at this site

• A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria — Running, not enrolling
• A Study of Erlotinib (Tarceva) After Surgery With or Without Adjuvant Chemotherapy in Non-Small Cell Lung Carcinoma (NSCLC) Patients Who Have Epidermal Growth Factor Receptor (EGFR) Positive Tumors — Completed